We hypothesize that Arfip2 deficiency mediates the dysregulation of mitophagy and autophagy in diabetic nephropathy, leading to cellular dysfunction, inflammation, fibrosis, apoptosis, senescence, and renal hypoxia. This evidence concerns the gene ARFIP2 and diabetic kidney disease.